Csl Behring Gmbh
SpainAll drugs from this manufacturer
-
It is used to treat and prevent bleeding episodes in people with hemophilia A (congenital factor VIII deficiency). It helps the blood clot normally by replacing the missing protein.
Dosage form: powder and solvent for solution for injection
Active substance Dosage lonoctocog alfa 400 UI -
It is used to treat and prevent bleeding episodes in people with hemophilia A (congenital factor VIII deficiency). It helps the blood clot normally by replacing the missing protein.
Dosage form: powder and solvent for solution for injection
Active substance Dosage lonoctocog alfa 400 UI -
It is used to treat and prevent bleeding episodes in people with hemophilia A (congenital factor VIII deficiency). It helps the blood clot normally by replacing the missing protein.
Dosage form: powder and solvent for solution for injection
Active substance Dosage lonoctocog alfa 100 UI -
It is used to treat and prevent bleeding episodes in people with hemophilia A (congenital factor VIII deficiency). The medication helps the blood clot normally by replacing the missing protein.
Dosage form: powder and solvent for solution for injection
Active substance Dosage lonoctocog alfa 200 UI -
It is used to restore and maintain circulating blood volume, especially in intensive care situations where blood volume has decreased dangerously, such as in cases of severe blood loss due to wounds or extensive burns.
Dosage form: solution for infusion
Active substance Dosage human albumin 50 g -
It is used in patients aged 12 years and older with hereditary angioedema (HAE) to prevent swelling attacks.
Dosage form: solution for injection
Active substance Dosage garadacimab 200 mg -
It is used to prevent or stop bleeding caused by a lack of factor VIII in the blood (hemophilia A) or to treat acquired deficiency of this factor.
Dosage form: powder and solvent for solution for injection and for infusion
Active substance Dosage factor viii 1000 UI water for injection preparations 10 ml -
It is used to prevent or stop bleeding caused by a lack of factor VIII in the blood (hemophilia A) or to treat acquired deficiency of this factor.
Dosage form: powder and solvent for solution for injection and for infusion
Active substance Dosage factor viii 500 UI -
It is used to treat and prevent type I and type II hereditary angioedema attacks. This disease causes sudden swelling in the hands, feet, face, eyelids, lips, tongue, or larynx, and can also cause abdominal pain.
Dosage form: powder and solvent for solution for injection and for infusion
Active substance Dosage c1 esterase inhibitor 12001875 UI -
It is used to prevent recurrent attacks of hereditary angioedema (HAE) in adolescents and adults. HAE is a disease that causes sudden swelling in the hands, feet, face, eyelids, lips, tongue, or abdomen.
Dosage form: powder and solvent for solution for injection
Active substance Dosage c1 esterase inhibitor 3000 UI -
It is used for the treatment and prevention of hereditary angioedema attacks (type I and II) before surgery. Angioedema is a disease that causes sudden swelling in the hands, feet, face, lips, tongue, or abdomen.
Dosage form: powder for injectable solution and for perfusion
Active substance Dosage c1 esterase inhibitor 400-625 U -
It is used to prevent bleeding during surgery or to treat hemorrhages caused by a deficiency of certain coagulation factors in the blood (factors II, VII, IX, and X).
Dosage form: powder and solvent for solution for injection
Active substance Dosage factor ii 800-1920 UI factor vii 400-1000 UI factor ix 800-1240 UI factor x 880-2400 UI protein c 600-1800 UI protein s 480-1520 UI -
It is used to prevent and treat bleeding caused by a lack of certain coagulation factors (II, VII, IX, and X) in the blood, whether due to a congenital or acquired deficiency, provided that specific products for each factor are not available.
Dosage form: powder and solvent for solution for injection
Active substance Dosage factor ii 400-960 UI factor vii 200-500 UI factor ix 400-620 UI factor x 440-1200 UI protein c 300-900 UI protein s 260-520 UI -
It is used in adults and children for the preventive treatment of hereditary factor XIII deficiency and to treat surgical bleeding in patients with congenital deficiency of this factor.
Dosage form: powder and solvent for solution for injection and for infusion
Active substance Dosage factor xiii 200-300 UI -
It is used to treat severe and moderately severe hemophilia B in adults who do not have or have not had inhibitors (antibodies) against the factor IX protein.
Dosage form: solution for infusion, concentrate
Active substance Dosage etranacogen dezaparvovec 1x10E13 Copias genómicas -
It is used to raise immunoglobulin levels in the blood in adults and children with immunodeficiencies (primary or secondary) and also to treat chronic inflammatory demyelinating polyneuropathy (CIDP), an autoimmune disease that affects the nerves.
Dosage form: solution for injection
Active substance Dosage normal human immunoglobulin 200 mg/ml -
It is used to raise immunoglobulin levels in the blood when they are abnormally low. It is prescribed in both adults and children to treat primary or secondary immunodeficiencies, and also to treat chronic inflammatory demyelinating polyneuropathy (CIDP).
Dosage form: solution for injection
Active substance Dosage normal human immunoglobulin 200 mg -
It is used to raise immunoglobulin levels in the blood in adults and children with immunodeficiencies (primary or secondary) and also to treat chronic inflammatory demyelinating polyneuropathy (CIDP), an autoimmune disease that affects the nerves.
Dosage form: solution for injection
Active substance Dosage normal human immunoglobulin 200 mg -
It is used to raise immunoglobulin levels in the blood in adults and children who have low levels due to genetic or acquired conditions. It is also used to treat chronic inflammatory demyelinating polyneuropathy (CIDP), an autoimmune disease that affects the nerves.
Dosage form: solution for injection
Active substance Dosage normal human immunoglobulin 200 mg -
It is used to restore and maintain circulating blood volume, especially in intensive care situations where blood volume has dangerously decreased, such as after severe blood loss due to an injury or extensive burns.
Dosage form: solution for infusion
Active substance Dosage human albumin 200 g/l -
It is used to prevent or stop bleeding in patients of all ages with hemophilia B (also known as Christmas disease), due to a lack of sufficient factor IX in the blood.
Dosage form: powder and solvent for solution for injection
Active substance Dosage albutrepenonacog alfa 1.000 UI -
It is used to prevent or stop bleeding in patients of all ages with hemophilia B (also known as Christmas disease), due to the lack of sufficient factor IX in the blood.
Dosage form: powder and solvent for solution for injection
Active substance Dosage albutrepenonacog alfa 2.000 UI -
It is used to prevent or stop bleeding in patients of any age with hemophilia B (also known as Christmas disease), due to the lack of factor IX in their blood.
Dosage form: powder and solvent for solution for injection
Active substance Dosage albutrepenonacog alfa 250 UI -
It is used to prevent or stop bleeding caused by a lack of sufficient factor IX in patients of all ages with hemophilia B (also known as Christmas disease).
Dosage form: powder and solution for injection
Active substance Dosage albutrepenonacog alfa 700 UI/ml -
It is used to prevent or stop bleeding in patients of all ages with hemophilia B (also known as Christmas disease or congenital factor IX deficiency). The medication helps the blood to clot by replacing the missing factor IX.
Dosage form: powder and solvent for solution for injection
Active substance Dosage albutrepenonacog alfa 500 UI -
It is used to treat adults and children with low levels of immunoglobulin in the blood (due to primary or acquired immunodeficiencies) and to treat various inflammatory disorders, such as immune thrombocytopenic purpura, Guillain-Barré syndrome, Kawasaki disease, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuropathy.
Dosage form: solution for infusion
Active substance Dosage normal human immunoglobulin 100 mg -
It is used to treat adults and children with low levels of immunoglobulin in the blood (due to primary or acquired immunodeficiencies) and to treat certain inflammatory disorders such as Immune Thrombocytopenic Purpura, Guillain-Barré syndrome, Kawasaki disease, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuropathy.
Dosage form: solution for infusion
Active substance Dosage normal human immunoglobulin 100 mg -
It is used to treat adults and children with low levels of immunoglobulin in the blood (due to primary or acquired immunodeficiencies) and to treat certain inflammatory disorders such as Immune Thrombocytopenic Purpura, Guillain-Barré syndrome, Kawasaki disease, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuropathy.
Dosage form: solution for infusion
Active substance Dosage normal human immunoglobulin 100 mg -
It is used to treat adults and children with low levels of immunoglobulin in the blood (due to primary or acquired immunodeficiencies) and to treat certain inflammatory disorders such as Immune Thrombocytopenic Purpura, Guillain-Barré syndrome, Kawasaki disease, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuropathy.
Dosage form: solution for infusion
Active substance Dosage normal human immunoglobulin 100 mg -
It is used to treat adults and children with low levels of immunoglobulin in the blood (due to primary or acquired immunodeficiencies) and to treat certain inflammatory disorders such as immune thrombocytopenic purpura, Guillain-Barré syndrome, Kawasaki disease, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuropathy.
Dosage form: solution for infusion
Active substance Dosage normal human immunoglobulin 100 mg -
It is used in adults with a known severe alpha1-proteinase inhibitor deficiency who have developed emphysema. Regular use helps to slow the progression of this lung condition.
Dosage form: powder and solvent for solution for infusion
Active substance Dosage alpha-1 proteinase inhibitor 1000 mg -
It is used in adults with a known severe alpha1-proteinase inhibitor deficiency who have developed emphysema. Regular use helps to slow the progression of this lung condition.
Dosage form: powder and solvent for solution for infusion
Active substance Dosage alpha-1 proteinase inhibitor 50 mg/ml -
It is used in adults with a known severe alpha1-proteinase inhibitor deficiency who have developed emphysema. Regular use helps to slow the progression of this lung disease.
Dosage form: powder and solvent for solution for infusion
Active substance Dosage alpha-1 proteinase inhibitor 50 mg/ml -
It is used to prevent isoimmunization in Rh(D)-negative women who are pregnant or have had an Rh(D)-positive baby, or who have experienced complications such as miscarriages, loss of a baby, or hemorrhages. It is also used in Rh(D)-negative adults, children, or adolescents who have accidentally received an Rh(D)-positive blood transfusion.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage human anti-d immunoglobulin 300 µg -
It is used to treat bleeding in people with a congenital fibrinogen deficiency (hypo- or afibrinogenemia) who have a tendency to bleed.
Dosage form: powder for injectable solution and for perfusion
Active substance Dosage human fibrinogen 1 g